Yatharth Hospital Q1 Revenue Jumps 51% to ₹393 Crore on NCR Expansion

Market snapshot: Yatharth Hospital & Trauma Care Services Limited delivered strong Q1 FY27 results, reporting a 51.5% YoY revenue surge to ₹392.65 crore. Consolidated net profit rose 11.9% YoY to ₹47.06 crore, driven by robust contributions from newly commissioned assets in Delhi-NCR and Agra. Margin contraction of 167 bps was observed due to initial ramp-up losses.

Data Snapshot

• Operating Revenue: ₹392.65 crore (+51.5% YoY)
• Consolidated PAT: ₹47.06 crore (+11.9% YoY)
• EBITDA: ₹91.70 crore (+39.1% YoY)
• EBITDA Margin: 23.35% (-167 bps YoY)
• ARPOB: ₹34,758 (+7.3% YoY)
• Occupancy: 68% (vs 65% YoY)

What's Changed

• Operating revenue rose to ₹392.65 crore from ₹257.77 crore YoY, while PAT rose to ₹47.06 crore from ₹42.04 crore YoY.
• Top-line revenue increased by ₹134.88 crore, whereas consolidated bottom-line profit grew by ₹5.02 crore.
• Newly commissioned hospitals contributed ₹106.70 crore (27% of group revenue), showcasing rapid gestational turnarounds.

Key Takeaways

• Quick Breakeven: Faridabad Sector-20 achieved EBITDA breakeven in nine months, while Agra hospital delivered a 20%+ EBITDA margin.
• Premium ARPOB: Average Revenue Per Occupied Bed grew 7.3% to ₹34,758.
• Bed Expansion: June 2026 Gurugram acquisition of 250 beds takes total network capacity past 2,800 beds.

SAHI Perspective

Yatharth’s aggressive expansion strategy is unlocking strong operating leverage. Although margin contraction to 23.35% reflects short-term gestation costs, the rapid turnaround of Faridabad and Agra assets validates management's execution capability. Backed by a healthy net-cash balance and maiden dividends, Yatharth remains structurally attractive.

Market Implications

Top-line results reinforce investor confidence in regional mid-sized hospital models. The cluster-expansion strategy in the high-ARPOB NCR market positions Yatharth for premium care demand. The maiden dividend signals strong capital allocation discipline.

Trading Signals

Market Bias: Bullish

Yatharth Hospital's robust 51.5% top-line revenue growth to ₹392.65 crore and rapid EBITDA breakeven in Faridabad indicate strong earnings expansion potential, offsetting short-term margin compression.

Overweight: Healthcare, Hospitals, Pharmaceuticals

Underweight: Consumer Discretionary, Auto Components

Trigger Factors:

• Occupancy levels in Faridabad and Gurugram hospitals
• ARPOB trajectory towards ₹36,000
• EBITDA margin recovery from 23.35%

Time Horizon: Medium-term (3-12 months)

Industry Context

India’s private healthcare sector is consolidating rapidly. Regional leaders like Yatharth are filling micro-market gaps across NCR and Central India. Growth in high-value specialties drives higher ARPOBs, enabling corporate hospital networks to consistently outpace public alternatives.

Key Risks to Watch

• Squeezed near-term operating margins from gestation losses.
• Delayed commissioning of the 250-bed Gurugram facility.
• Regulatory price controls.

Recent Developments

In June 2026, Yatharth completed the ₹100 crore Sector-40 Gurugram hospital asset acquisition, adding 250 beds. It also hosted an investor meet in July 2026 to showcase its 11% ARPOB expansion, and in August 2026, approved the ESOP 2026 scheme.

Closing Insight

Yatharth’s repeatable inorganic growth model continues to bear fruit. Converting underperforming acquired hospitals into profit centers quickly is its core operational strength.

High Performance Trading with SAHI.